Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.20−0.27 (-4.17%)
Close on Nov 17, 2026Market cap $95.85MP/E –Yield –
Satellos Bioscience operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$23.60M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.60M | – |
| FY2024 | Dec 31, 2024 | -$18.25M | – |
See a number that looks wrong?